CNTB vs COCP

Connect Biopharma Holdings Limi vs Cocrystal Pharma, Inc. — Valuation Comparison 2026

CNTB

Biotechnology
Connect Biopharma Holdings Limi
Quality
5.1
out of 10
Value Trap
6
SAFE
Price
$2.38
Last close
Models
9/13
Active
VS

COCP

Biotechnology
Cocrystal Pharma, Inc.
Quality
4.3
out of 10
Value Trap
24
SAFE
Price
$1.13
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType CNTB Fair ValueCNTB Upside COCP Fair ValueCOCP Upside
Bayesian DCF Intrinsic $1.07 -54.9% $0.45 -60.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.85 -64.2% $0.05 -96.4%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CNTB vs COCP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CNTB vs COCP — Which Stock Is More Undervalued?

CNTB scores higher with a 5.1/10 quality rating vs COCP's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Connect Biopharma Holdings Limi (CNTB) and Cocrystal Pharma, Inc. (COCP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CNTB currently trades at $2.38 with a QOC of 5.1/10, while COCP trades at $1.13 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).